Journal of Clinical Oncology · 1992 · 263 citations · 13 references
Despite the fact that patients who received chemotherapy (group 1) had more advanced disease compared with those with resectable disease (group 3), the addition of LV/5-FU increased the resectability and downstaging rates. The ultimate impact of a complete response as well as a decrease in the incidence of pelvic nodes on local control and survival remains to be determined. However, given the enhancement of down-staging in patients with unresectable rectal cancer, we are encouraged by the combined modality approach.
13
Effective Surgical Adjuvant Therapy for High-Risk Rectal Carcinoma
James E. Krook, C G Moertel, Leonard L. Gunderson et al. · New England Journal of Medicine · 1991 · 1.9K citations
Biostatistics -- An Introductory Text
L. N. Balaam, Avram Goldstein · Biometrics · 1965 · 807 citations